We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

171 hedge funds and large institutions have $877M invested in Ariad Pharmaceuticals Inc in 2014 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 56 increasing their positions, 48 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

20% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 30

17% more repeat investments, than reductions

Existing positions increased: 56 | Existing positions reduced: 48

10% more capital invested

Capital invested by funds: $801M → $877M (+$76.3M)

3% more funds holding

Funds holding: 166 → 171 (+5)

7% more call options, than puts

Call options by funds: $53.1M | Put options by funds: $49.5M

0% more funds holding in top 10

Funds holding in top 10: 4 → 4 (0)

Holders
171
Holders Change
+5
Holders Change %
+3.01%
% of All Funds
4.94%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.12%
New
36
Increased
56
Reduced
48
Closed
30
Calls
$53.1M
Puts
$49.5M
Net Calls
+$3.61M
Net Calls Change
+$16.2M

Top Buyers

Rank Fund Capital Flow
1
SPC
Slate Path Capital
New York
+$51.6M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
+$24.7M
3
Renaissance Technologies
Renaissance Technologies
New York
+$17.5M
4
Deutsche Bank
Deutsche Bank
Germany
+$7.73M
5
ARTA
A.R.T. Advisors
New York
+$4.43M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$28.7M
2
CCM
Camber Capital Management
Massachusetts
-$17.5M
3
Franklin Resources
Franklin Resources
California
-$16.7M
4
Barclays
Barclays
United Kingdom
-$14M
5
PC
PointState Capital
New York
-$12.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fifth Third Bancorp
151
Fifth Third Bancorp
Ohio
$12K +$11.7K +1,500 New
OIA
152
Optimum Investment Advisors
Illinois
$12K +$11.7K +1,500 New
LNB
153
Ledyard National Bank
$8K – – –
MCM
154
Manchester Capital Management
Vermont
$8K – – –
OSNBOA
155
Old Second National Bank of Aurora
Illinois
$8K – – –
RFC
156
Russell Frank Company
Washington
$7K +$7.96K +1,022 New
TCOV
157
Trust Company of Vermont
Vermont
$5K – – –
MFS
158
MSI Financial Services
Massachusetts
$5K +$5.05K +648 +32,400%
KT
159
Kanaly Trust
Texas
$4K – – –
BRWM
160
B. Riley Wealth Management
Tennessee
$4K +$3.89K +500 New
TDC
161
Thompson Davis & Co
Virginia
$4K +$3.89K +500 New
DADC
162
D.A. Davidson & Co
Montana
$3K +$2.61K +335 +515%
TCM
163
Tradewinds Capital Management
Washington
$3K +$3.12K +400 New
SNT
164
Security National Trust
West Virginia
$2K – – –
BNP Paribas Financial Markets
165
BNP Paribas Financial Markets
France
$1.49K -$818 -105 -34%
LWA
166
Lenox Wealth Advisors
New York
$1K – – –
PIM
167
Parasol Investment Management
Illinois
$1K – – –
AWM
168
Avior Wealth Management
Nebraska
$1K +$1.36K +175 New
Manulife (Manufacturers Life Insurance)
169
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$44 – – –
Walleye Trading
170
Walleye Trading
New York
$43 +$22.1K +2,833 +112%
AGCJ
171
Alden Global Capital (Jersey)
Jersey
– -$7.2M -1,055,900 Closed
PRCM
172
Pine River Capital Management
Minnesota
– -$1.68M -246,700 Closed
PCA
173
Private Capital Advisors
Connecticut
– -$1.43M -210,000 Closed
GTC
174
Ghost Tree Capital
New York
– -$887K -130,000 Closed
SCA
175
SAC Capital Advisors
Connecticut
– -$640K -93,800 Closed
4 5 6
7
8

ARIA Hedge Fund Activity: Q1 2014 in Review

171 of the 3,463 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q1 2014, worth a combined $877M — up 9.5% from $801M a quarter earlier.

Buyers outnumbered sellers: 36 funds opened new ARIA positions and 30 closed out — a net gain of 6 holders — while 56 added to existing stakes and 48 trimmed.

The largest buyer was Slate Path Capital, opening a new position worth an estimated $51.6M. The largest seller was Fidelity Investments, cutting an estimated $28.7M.

  • 171 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q1 2014, up from 166 in Q4 2013.
  • Funds reported $877M of Ariad Pharmaceuticals Inc stock for Q1 2014, up 9.5% quarter-over-quarter.
  • 36 funds opened new Ariad Pharmaceuticals Inc positions in Q1 2014 and 30 closed out, a net change of +6 holders.
  • The largest Ariad Pharmaceuticals Inc buyer in Q1 2014 was Slate Path Capital, an estimated $51.6M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q1 2014 was Fidelity Investments, an estimated $28.7M sold.

Based on aggregated 13F filings for Q1 2014.